PEPID Connect Help
View Tutorial
Contact PEPID Support
Suggest an edit
Current tool:
Current monograph:
Hello, PEPID User
PEPID
Subsections
Rhabdomyolysis

Nephrology

Rhabdomyolysis

Background

  1. Definition
    • Muscle injury that can lead to various forms of systemic insult, such as
      • Acute kidney injury (AKI)
      • Electrolyte imbalance
      • Disseminated intravascular coagulation (DIC)
  2. Synopsis
    • Medical management includes:
      • ABCs (Airway, Breathing, Circulation)
      • Identification/correction of the etiology
      • Fluid resuscitation, prevention of AKI/acute renal failure (e.g., Urinary alkalization, mannitol, loop diuretics)
      • Correction of electrolyte, acid-base, metabolic abnormalities
      • Hemodialysis (severe cases)

Pathophysiology

  1. Mechanism
    • Clinical syndrome of muscle injury with myoglobinuria, electrolyte abnormalities, and often associated kidney injury
      • Often defined as CK > 5-10 times upper limit of normal for reference population
    • Results from direct injury to myocyte membranes resulting in altered energy production, increased intracellular calcium levels, leading to release of myoglobin
      • Leakage of muscle cell contents into circulation
      • Myoglobin concentrates along renal tubules resulting in proximal tubular
      • Cytotoxicity and distal tubular obstruction
  2. Etiology/Risk Factors
    • Trauma
      • Crush injury
      • Taser (or similar device) shocks (behavior leading to the use of Taser more likely to cause rhabdomyolysis than the shock itself)
    • Exertion
      • Strenuous exercise, seizures
    • Muscle hypoxia
      • Limb compression
      • Arterial occlusion (thrombosis, atherosclerosis, sickle cell, vasculitis)
      • Compartment syndrome
    • Genetic defects (e.g., carbohydrate metabolism disorder)
    • Infections
      • Sepsis
      • Legionella, bacterial pyomyositis
      • Viral myositis (influenza)
    • Body temp dysregulation
      • Heat stroke, malignant hyperthermia
    • Metabolic or electrolyte disorders
    • Drugs and toxins
      • Lipid lowering drugs
      • Statin monotherapy has lower risk than combination statin-fibrate therapy
        • Severe rhabdomyolysis from statin therapy requiring hospitalization is rare
        • CYP interactions may increase risk
      • Alcohol
      • Mushroom Tricholoma equestre
      • Haff disease (after fish consumption)
      • Snake envenomations, particularly Timber (canebrake) rattlesnake and Mojave rattlesnake
    • Any drugs of abuse (particularly opioids such as heroin)
      • That cause rapid sedation and immobility (e.g., antipsychotics, anticholinergics)
      • That lead to temperature dysregulation, agitation, or neuromuscular agitation
        • Cocaine, amphetamines, MDMA (ecstasy) or phenylalkylamines ("bath salts"), anti-psychotics or anticholinergics
      • That lead to neuroleptic malignant syndrome (NMS) or serotonin syndrome
    • Idiopathic
  3. Epidemiology
    • Incidence/Prevalence
      • Approximately. 26,000 cases annually
      • Most adult cases of rhabdomyolysis are due to
        • Abuse of illicit drugs or alcohol
        • Muscular trauma
        • Crush injuries
        • Myotoxic effects of prescribed drugs
        • Found in 24% of adult patients who present to emergency departments (EDs) with cocaine-related conditions
    • Mortality/Morbidity
      • Overall mortality: 5%
        • Risk of death dependent on underlying etiology, any existing comorbid conditions, in patients with AKI, and extremely elevated CPK levels
      • Rapid appropriate supportive treatment of rhabdomyolysis-related kidney injury and renal failure improves prognosis

Diagnostics

  1. History/Symptoms
    • Classic triad
      • Muscle pain (< 50%)
      • Weakness (< 50%)
      • Dark urine
    • Malaise, fatigue, N/V
    • Careful history of
      • Prescription, non-prescription/OTC/herbal medications
      • Look for drug interactions
    • Substance abuse history
    • May lead to
      • Acute renal failure
      • Disseminated intravascular coagulation
      • Metabolic acidosis
  2. Physical Exam/Signs
    • General Appearance, Vitals
      • Fever, tachycardia
      • May appear acutely ill
    • Musculoskeletal/Nervous System
      • Muscle tenderness
    • Skin/Extremities
      • Crush injury, bruising, blebs, tense compartments
  3. Labs/Tests
    • CBC +Diff, CMP
    • ESR, CRP
    • CPK is the most sensitive indicator of muscle injury
      • Rises in 12 hrs, peaks 1-3 days, declines 3-5 days
      • > 5-10 x upper level of normal (~1000 U/L)
      • Severe rhabdomyolysis usually defined by CPK > 5,000 U/L
      • Risk for kidney injury usually occurs > 3-5,000 U/L range in previously healthy patients
      • Risk occurs at lower levels if poor baseline renal function
    • Myoglobinuria
      • Inferred by a positive urine dip with little/no RBCs
      • Myoglobin will also react with the orthotolidine test reagent
    • Electrolyte abnormalities
      • Increased potassium, phosphate, uric acid
      • Calcium initially decreases then gradually increases
        • Initially low due to precipitation with phosphates in muscle
        • Later calcium is released from damaged muscles
    • Urinalysis
  4. Other Tests/Criteria
    • McMahon Score for Rhabdomyolysis (Open Calc)
    • EKG
      • May show
        • Peaked T waves
        • Prolonged PR interval
        • Wide QRS interval w/ or w/o conduction blocks
        • Ventricular tachycardia
        • Asystole secondary to hyperkalemia
      • Hypocalcemia may manifest as QTc prolongation
  5. Differential Diagnosis

Treatment

  1. Initial/Prep/Goals
    • ABCs, IV access, monitor
    • Goals:
      • Prevent renal failure
      • Manage life -threatening complications
    • Stop ongoing cellular injury, prevent renal injury, treat complications
      • Treat underlying cause, stop ongoing muscle injury
      • Stop seizures, reduce temp (if hyperthermic) aggressively
      • Treat overdose or underlying disease process
      • Discontinue offending meds
      • Treat compartment syndrome (fasciotomy)
    • Sedate combative patients, benzodiazepines are typically used
      • Chemical restraint and environmental control is preferable to physical restraints in these patients
      • Consider paralysis and intubation
    • Early aggressive repletion of fluids
      • Volume depletion results from sequestration of water in injured muscles
      • IVF admin important even if not hypovolemic
      • Goal urine output of 300 ml/hr in adults (or 3 ml/kg/hr)
        • Depending on severity and comorbidities
      • Fluid composition is controversial
    • Correct electrolyte disorder
      • Hyperkalemia
      • Hypocalcemia: avoid correcting early in process unless symptomatic or severe hyperkalemia
      • Avoid nephrotoxic substances
        • NSAIDs, IV contrast, nephrotoxic antibiotics
  2. Medical/Pharmaceutical
    • Normal (isotonic) saline
      • First-line treatment
      • Total of 10-20 L often administered in the first 24 hr
      • Titrate to urinary output of >300 mL/hr
      • Continue until CPK is < 1000 units/L
      • In disaster situations give first bolus during extrication of victims
      • Lactated ringers have benefit of increasing serum and urine pH, but thus far no proven clinical advantage
      • No evidence that adding bicarbonate (D5W + 2 amps HCO3/L) is superior to using normal saline alone
      • Theoretically: alkalinization of urine may prevent precipitation of myoglobin in renal tubules
    • Adjunctive therapies
      • Mannitol:
        • 1g/kg IV over 30 minutes or 25 g IV bolus followed by 5 g/hr infusion
        • No more than 200 g/day; can cause an osmotic nephrosis
        • Multiple studies have failed to find a benefit with mannitol administration
        • Use only in conjunction with adequate fluid administration
        • Monitor plasma osmolality and osmolar gap
        • Discontinue if osmolar gap >55 mOsm/kg
      • Furosemide: no proven benefit
  3. Surgical/Procedural
    • Hemodialysis
      • Profound refractory hyperkalemia, acidosis or volume overload
  4. Complications
    • Compartment syndrome
      • Surgical decompression with fasciotomy
      • Mannitol may assist in reducing compartment pressures
    • Cardiac arrhythmias
    • Higher peak CPK, hypoalbuminemia, and metabolic acidosis are factors associated with a higher mortality
      • Mortality more dependent on etiology or rhabdomyolysis (i.e., poly-trauma or burn patients have higher mortality)
    • Acute kidney injury
    • Electrolyte abnormalities
    • DIC
    • End-stage renal disease
      • Requiring prolonged renal replacement therapy
    • Infections from prolonged hospital stay
    • Shock (low blood pressure)
  5. Prevention
    • Drink plenty of fluids during strenuous exercise or damaged skeletal muscles
    • Prompt treatment of underlying etiology

Disposition

  1. Admission Criteria
    • Patients with significant or ongoing rhabdomyolysis should be admitted for IV hydration, diuresis and management of complications
      • ICU for severe complications or metabolic derangements
      • Mild elevations of CPK (< 1,000 U/L) likely to be well tolerated if normal renal function if etiology is discovered and treated/stopped
        • CPK takes hours to peak
        • Initial level may be low; need to trend levels over time
  2. Consult(s)
    • Intensivist, nephrology, surgery (trauma, vascular or orthopedic) as needed
  3. Discharge/Follow-up Instructions
    • Follow-up as per care team plan
    • Educate pt on condition and treatment
    • Many patients take months to recover the muscle mass even after recovery
      • Some may even have residual pain for a few years

References

  1. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009;361:62-72
  2. Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013;144(3):1058-1065
  3. Sutamtewagul G, Sood V, Nugent K. Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following "bath salts" injection. Clin Nephrol. 2014 Jan;81(1):63-66
  4. Rodríguez E, Soler MJ, Rap O, Barrios C, Orfila MA, Pascual J. Risk factors for acute kidney injury in severe rhabdomyolysis. PLoS One. 2013;8(12)
  5. Scharman EJ, Troutman WG. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother. 2013;47(1):90-105
  6. Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma. 2004;56(6):1191-1196
  7. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009;361:62-72
  8. O'Connor FG, Deuster PA. Rhabdomyolysis. In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011;Chapter 115
  9. Scharman EJ, Troutman WG: Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother 47:90–105, 2013.
  10. Walls RM, Hockberger RS, Gausche-Hill M. Rosen's Emergency Medicine - Concepts and Clinical Practice, 9th ed, Philadelphia, PA;Elsevier-Saunders, 2018;Chapter 119
  11. Rhabdomyolysis. StatPearls [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK448168/. [Accessed November 2023]

Contributor(s)

  1. Punja, Mohan, MD
  2. Ballarin, Daniel, MD

Updated/Reviewed: November 2023